'Vaccines won't work': US virologist breaks down COVID-19, how to curb spread [VIDEO] - The Korea Times
The Korea Times

Settings

ⓕ font-size

  • -2
  • -1
  • 0
  • +1
  • +2

'Vaccines won't work': US virologist breaks down COVID-19, how to curb spread [VIDEO]



Video by Lee Min-young, Kim Kang-min

Lessons learned from virologist Dr. Hakim Djaballah about COVID-19, caused by the SARS-CoV2 virus, can be summed up in several notes. Check out the video interview with Dr. Djaballah for more in-depth information.

- How much do we know about this virus?
- How far are we from developing a vaccine?
- Who holds the key to understanding the nature of COVID-19?
- The debate: Mask or no mask?
- Why don't we have a vaccine for SARS-CoV1 yet?
- Can we stop the spread? How?
- Lessons to learn from the COVID-19 outbreak.



Dr. Hakim Djaballah is an Algerian-born American molecular pharmacologist and technologist with expertise in virology and oncology. Dr. Djaballah is a thought leader on drug discovery and development and sits on several advisory boards. He is the co-founder, president and CEO of Keren Therapeutics, a startup company dedicated to the science of aging. Formerly, Dr. Djaballah was the CEO of the Pasteur Institute in Korea, a transnational research institute with a focus on infectious diseases and oncology. Prior to his move to South Korea, Dr. Djaballah was affiliated with the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, USA. MSKCC is the oldest cancer treatment and research institution, founded in 1884. Dr. Djaballah holds a BSc degree from the University of Birmingham (England) and a doctorate degree from the University of Leicester (England).




Video by Lee Min-young, Kim Kang-min

Lessons learned from virologist Dr. Hakim Djaballah about COVID-19, caused by the SARS-CoV2 virus, can be summed up in several notes. Check out the video interview with Dr. Djaballah for more in-depth information.

- How much do we know about this virus?
- How far are we from developing a vaccine?
- Who holds the key to understanding the nature of COVID-19?
- The debate: Mask or no mask?
- Why don't we have a vaccine for SARS-CoV1 yet?
- Can we stop the spread? How?
- Lessons to learn from the COVID-19 outbreak.



Dr. Hakim Djaballah is an Algerian-born American molecular pharmacologist and technologist with expertise in virology and oncology. Dr. Djaballah is a thought leader on drug discovery and development and sits on several advisory boards. He is the co-founder, president and CEO of Keren Therapeutics, a startup company dedicated to the science of aging. Formerly, Dr. Djaballah was the CEO of the Pasteur Institute in Korea, a transnational research institute with a focus on infectious diseases and oncology. Prior to his move to South Korea, Dr. Djaballah was affiliated with the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, USA. MSKCC is the oldest cancer treatment and research institution, founded in 1884. Dr. Djaballah holds a BSc degree from the University of Birmingham (England) and a doctorate degree from the University of Leicester (England).


Lee Min-young minlee@koreatimes.co.kr


X
CLOSE

Top 10 Stories

go top LETTER

The Korea Times

Sign up for eNewsletter